Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar:182:73-84.
doi: 10.1016/j.biochi.2020.12.022. Epub 2021 Jan 12.

Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model

Affiliations

Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model

Alvi Yasmin et al. Biochimie. 2021 Mar.

Abstract

Hepatocellular carcinoma (HCC) is the 5th most common and 2nd deadliest cancer worldwide. HCC risk factors include alcohol induced liver cirrhosis, which prompts hepatic inflammation, cell necrosis, and fibrosis deposition. As 25% of HCC cases are associated with alcohol induced liver disease, understanding the effects of the cirrhotic liver microenvironment on HCC tumor biology and therapeutic responses are critical. This study utilized the Oncopig Cancer Model-a transgenic pig model that recapitulates human HCC through induced expression of KRASG12D and TP53R167H driver mutations-to investigate the molecular mechanisms underlying alcohol induced liver disease. Oncopigs (n = 5) underwent fibrosis induction via infusion of ethanol and ethiodized oil (1:3 v/v dosed at 0.75 mL/kg) into the hepatic arterial circulation. Eight-weeks post induction, liver tissue samples from fibrotic and age-matched control (n = 5) Oncopigs were collected for histological evaluation and transcriptional profiling. Increased hepatic inflammation and fibrosis was observed in fibrotic Oncopigs via pathological assessment. Transcriptional profiling (RNA-seq) resulted in the identification of 4387 differentially expressed genes between Oncopig fibrotic and control livers. GO term enrichment analysis identified pathway alterations associated with cirrhosis progression in humans, including cell proliferation, angiogenesis, extracellular matrix deposition, and oxidation-reduction. Key alterations include activation of hepatic stellate cells, increased matrix metalloproteinase production, and altered expression of ABC and SLC transporter genes involved in transport of anticancer drugs.These results demonstrate Oncopig liver fibrosis recapitulates transcriptional hallmarks of human cirrhosis, making the Oncopig an ideal model for studying the effects of the cirrhotic liver microenvironment on HCC tumor biology and therapeutic response.

Keywords: Alcoholic liver disease; Fibrosis; Matrix metalloproteinases; Pig cancer model; Translational research.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflict of interest RCG receives research funding from the National Insitute of Health, the United States Department of Defense, Guerbet USA LLC, and Janssen Research & Development LLC. KMS receives research funding from the National Insitute of Health, Guerbet USA LLC, and Janssen Research & Development LLC. AY, DPR, and LBS have no conflict of interest.

Figures

Fig. 1.
Fig. 1.. Alcohol exposure results in fibrosis induction in Oncopig livers.
Representative images of Masson’s trichrome-stained Oncopig liver sections (2.5X) histologically graded for fibrosis using a porcine adapted METAVIR scheme. (A) Control, histologically normal Oncopig liver with normal pre-existing fibrous septa and associated classic hepatic-lobule architecture. (B) F3 fibrosis grade demonstrating numerous inter- and intra-lobular dissecting fibrous septa present at 8 weeks post-induction. (C) METAVIR inflammation, fibrosis scores, and percent fibrosis for each samples 8 weeks post-induction.
Fig. 2.
Fig. 2.. Alcohol exposure results in reproducible alteration of hepatic gene expression profiles.
(A) PCA plot demonstrating clustering of samples by group based on the relative expression of 21,748 genes for which expression information was available for each sample. (B) Total number of DEGs, including those up- and down-regulated in the fibrotic compared to control group. (C) PCA plot demonstrating samples cluster by group based on the 4387 DEGs. (D) Heatmap of the normalized expression level of the 4387 DEGs for each sample, represented as z-scores. Dendrograms represent relationships between samples (columns) based on complete linkage clustering.
Fig. 3.
Fig. 3.. GO terms enriched for DEGs associated with liver cirrhosis progression.
GO terms enriched for the 4387 DEGs are associated with biological processes involved in human liver cirrhosis progression.
Fig. 4.
Fig. 4.. Downregulation of MYC associated with inactivation of HSCs.
(A) Reduced expression of MYC was observed in the Oncopig fibrotic liver samples. (B) Diagram depicting upregulation of MYC due to chronic alcohol abuse resulting in hepatic apoptosis and activation and proliferation, which contributes to accelerated liver fibrosis. Adopted from Nevzorova et al. [37]. * denotes q-value = 9.5 × 10−4.
Fig. 5.
Fig. 5.. Differential MMP and TIMP expression in fibrotic Oncopig livers.
Altered expression of MMPs and TIMPs in Oncopig fibrotic compared to control livers. * denotes q-value < 0.05.
Fig. 6.
Fig. 6.. Increased expression of proangiogenic factors.
Increased expression of proangiogenic factors in Oncopig fibrotic compared to control livers.
Fig. 7.
Fig. 7.. DEGs associated with oxidation-reduction processes.
Up-regulated and down-regulated DEGs associated with the oxidation-reduction GO term in Oncopig fibrotic compared to control livers.
Fig. 8.
Fig. 8.. Altered expression of ABC and SLC transporters.
Altered expression of (A) ABC and (B) SLC transporter genes in Oncopig fibrotic compared to control liver samples. Dendrograms represent relationships between samples (columns) based on complete linkage clustering.

References

    1. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012.
    1. Flores A, Marrero JA, Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics, Clin. Med. Insights Oncol 8 (2014) 71–76. - PMC - PubMed
    1. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM, Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States, Can. Res 74 (2014. June 1) 2913–2921. - PubMed
    1. Singal AG, El-Serag HB, Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice, Clin. Gastroenterol. Hepatol 13 (2015. November) 2140–2151. - PMC - PubMed
    1. Scaglione S, Kliethermes S, Cao G, et al., The epidemiology of cirrhosis in the United States: a population-based study, J. Clin. Gastroenterol 49 (2015. September) 690–696. - PubMed

MeSH terms